Investing Profile

Ken Sawyer

VCInvestorAngelFounder
Founder and Managing Director at Saints Capital
saintscapital.comUnited States
Photo of Ken Sawyer, Managing Director at Saints Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Saints Capital Managing Director
$250K - $100.0M
$10.0M
16
$27.4M
CompanyStageDateRound SizeTotal Raised
Direct Flow Medical
Series CApr 2016$31M
$110M
Co-investors: Jeani Delagardelle (New Leaf Venture Partners), Renee Compton Ryan (Johnson & Johnson Innovation), Annette Bianchi (VantagePoint Capital Partners)
Siftery
SeedFeb 2016$4M
$4M
Co-investors: Jeremy Philips (Spark Capital), Chris Scoggins (SignalFire), Kevin Mahaffey (Lookout), Eric Di Benedetto (quadratura.it), Julia Popowitz (Broadway Angels), Eric Ries (Long-Term Stock Exchange), Auren Hoffman (SafeGraph), Peter Kellner (Richmond Global Ventures), Travis May (Theodore Health), Tod Sacerdoti (Flex Capital, LLC // Turbo Ventures, LLC), Joanna Rees (University of Washington Applied Physics Laboratory), Patrick McKenna (High Ridge Venture Partners), Mitch Kitamura (DNX Ventures), Scott Faber (Betabrand), Ron Hirson (DocuSign), Itamar Novick (Recursive Ventures), Ethan Beard (Piazza Venture Labs), Michael Lazerow (Lazerow Ventures), Russell Fradin, Evangelos Simoudis, Eric Stein, Jay Weintraub, Mark Gerson, Russ Fradin, Charlie Songhurst, Joe Zawadzki, Adam D'Angelo, Jeremy Lizt
Fixt
SeedJan 2016$800K
$3.4M
Co-investors: Charles Hudson (Precursor Ventures), Chad Nitschke
Acsis
Series AApr 2015$250K
$250K
Gilt Groupe
Series FFeb 2015$50M
$270M
Co-investors: Randy Glein (DFJ), Anton Levy (General Atlantic), Dana Stalder (Matrix Partners India), Henry Fertik (Strategic Beta)
OrSense
Series HFeb 2015
Series HApr 2014
Debt FinancingJan 2014
Vidyo
Series EJul 2014$20M
Series DApr 2013$17M
$130M
Co-investors: Avery More (Menlo Ventures), Douglas Carlisle
Laureate Pharma
Debt FinancingOct 2010$20M
$20M
We provide liquidity for founders and investors for their private shares in great companies -usually mature enough to have meaningful revenue traction
Pre-revenue companies or shares in companies where the investors and founders are not supportive of a secondary transaction